Close Menu

No Place To Hide

When Pfizer bought Wyeth last year, the company said that it expected to cut about 15 percent of its workforce. However, on Friday, Pfizer said in a filing with the US Securities and Exchange Commission that the company will likely exceed that percentage, reports the Wall Street Journal. "At this point, it's too early to determine the extent to which we will exceed this target," says Joan Campion, a company spokesperson.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.